Several factors have accelerated the uptake of digital health technologies (DHTs) in clinical trials, including an increased market demand in general for digital technologies, the COVID-19 pandemic, and increased acceptance of DHTs by regulators.

This white paper highlights key considerations for Sponsors and CROs as they develop their DHT strategy, including:

• The rising adoption of digital health technologies in clinical trials
• Industry challenges
• A common data model
• Implementing an integrated data strategy